Cboe Global Markets (CBOE) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
5 May, 2026Executive summary
Achieved record net revenue of $728.9 million in Q1 2026, up 29% year-over-year, and record adjusted diluted EPS of $3.70, up 48%, driven by strong growth across derivatives, cash and spot markets, and Data Vantage segments.
Strategic realignment included the sale of Cboe Canada and Australia, winding down of non-core businesses, and a workforce reduction of approximately 20% to focus on core and growth areas.
Continued investment in global access, product innovation, and partnerships, including a new collaboration with CNBC and expansion into event contracts and binary options.
Leadership transitions included new appointments for COO and Global Head of Equities and Spot Markets.
Financial highlights
Adjusted operating EBITDA grew 41% to $540.8 million, with margin expanding to 74.2%; operating income rose 43% to $505.6 million.
Adjusted operating expenses rose 4% to $200.9 million, mainly due to higher compensation tied to strong revenue.
Cash and spot markets net revenue up 34%, derivatives up 32%, and Data Vantage up 19% year-over-year.
Global FX segment posted the strongest growth, with net revenue up 38% year-over-year.
Cash flow from operations was $1,960.0 million, up from $912.9 million in Q1 2025.
Outlook and guidance
2026 organic net revenue growth target raised to low double-digit to mid-teens; Data Vantage growth target increased to low double digits.
Adjusted operating expense guidance for 2026 lowered to $838–$853 million; CapEx guidance unchanged at $73–$83 million.
Effective tax rate for 2026 projected at 27.5%–29.5%.
Strategic realignment expected to yield $100M–$120M in annualized expense savings, with $20M–$25M realized in 2026.
Strategic realignment actions expected to be substantially completed by year-end 2026, with anticipated annualized pre-tax cost savings of $40–50M.
Latest events from Cboe Global Markets
- Board recommends all management proposals, highlights record performance, and opposes written consent rights.CBOE
Proxy filing2 Apr 2026 - Record revenue and margin growth in 2025, with strong outlook and focus on core innovation.CBOE
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Record Q4 and full-year growth in revenue and EPS, with robust 2026 outlook and strategic focus.CBOE
Q4 20256 Feb 2026 - S&P 500 variance futures launch September 23, 2024, improving access and transparency for variance trading.CBOE
Product Launch3 Feb 2026 - Record Q2 revenue and adjusted EPS growth, offset by a digital asset impairment.CBOE
Q2 20242 Feb 2026 - Record index option volumes and global expansion drive growth, with disciplined capital allocation.CBOE
Piper Sandler Global Exchange and Trading Conference 20241 Feb 2026 - Record growth in volatility products and index options, with global tech integration fueling expansion.CBOE
Barclays 22nd Annual Global Financial Services Conference 202421 Jan 2026 - Physically delivered VIX futures options launch October 14, expanding volatility management tools.CBOE
Product Launch19 Jan 2026 - Record net revenue and EPS growth driven by strong derivatives and global expansion.CBOE
Q3 202417 Jan 2026